logo
Bishop Auckland mother among 27 'poisoned' by fake Botox

Bishop Auckland mother among 27 'poisoned' by fake Botox

BBC News20-06-2025
In recent weeks, 28 people in the north-east of England have been left with potentially fatal botulism after having anti-wrinkle injections believed to have been fake. Such reactions are usually so rare hospitals stock very little anti-toxin and they were in danger of running out.
On one night in June five people were in an accident and emergency department (A&E) in Durham suffering from serious adverse effects of anti-wrinkle injections - Nicola Fairley was one of them.Within days of having what she was told was a Botox jab, but which turned out to be an illegal copy, her throat began closing up, an eye swelled shut and one side of her face started to droop. She could not smile, struggled to eat and swallow, felt exhausted and was desperate to sleep.The 37-year-old mother of four from Bishop Auckland in County Durham told staff she had been given injections and was unwell."They got the doctor to see me within five minutes and started some tests there and then," Mrs Fairley recalls.Of the 28 people, mostly in the Durham and Darlington areas, who have found themselves in a similar position, four others ended up in the same hospital on the same night as Mrs Fairley.In an average year, the University Hospital of North Durham usually sees no cases at all of botulism that require treatment. Only six were recorded in the whole of England in 2023-24.Since being approached by the BBC the Medicines and Healthcare products Regulatory Agency (MHRA) has set up an investigation.
Botulinum toxin is widely used to reduce facial wrinkles and treat muscle conditions. While cosmetic practitioners do not need to be licensed, the drug does. Only seven brands are licensed in the UK, with Botox the most well known.When used correctly the amounts are small and side effects are rare. But unregulated toxin, or larger quantities, can attack the nerves and cause botulism, a potentially life-threatening condition that causes paralysis. Mrs Fairley had anti-wrinkle injections before, paying £100 for three areas, but then won a round of treatment from the same provider in a competition. She was told it was a stronger type of the toxin and again had three areas injected.She says she had no idea this treatment was illegal.Within two hours her forehead was "frozen", although genuine cosmetic injections should take several days to start working with the full effect visible after two weeks. Of those in A&E at the same time, some had used the same practitioner as Mrs Fairley. They were all diagnosed with botulism and one doctor told the group they had never seen that many people with the condition at the same time.It is so rare, hospitals do not typically keep large quantities of the anti-toxin - made from horse blood - that is used to stop the toxin spreading further.
North Durham was already trying to source anti-toxin drugs from other hospitals as there had been a spate of cases in the days before Mrs Fairley and the others arrived in A&E.In an internal communication seen by the BBC, a hospital leader said: "We've just about exhausted all stock of the antitoxin from local holders (Newcastle, Carlisle and Leeds) and have 10 more coming from London." They were "bracing" themselves for more patients.The MHRA told the BBC it was investigating allegations surrounding the illegal sale and supply of fake "Botox-type" products in the North East. Chief safety officer Dr Alison Cave said the body's criminal enforcement unit "works hard to identify those involved in the illegal trade in medicines".Buying anti-wrinkle injections and other medicines from illegal suppliers significantly increased the risk of getting a product which is either "falsified or not authorised" for use in the UK, she said.
An aesthetic doctor based in Newcastle, Steven Land, believes anti-wrinkle injections in three areas for less than £150 is very cheap and this could suggest the supplier was using an illegal toxin. Dr Land, who has also worked in A&E, said he was contacted weekly by "fake pharmacies" offering to sell him the toxins for such small amounts he "knows they're illegal". Genuine injections were "very safe if done properly" but called for the industry to be regulated, he said. As things stand it is not regulated at all, with anyone able to provide cosmetic injections."Your provider should be able to show you the product they are using and be happy to answer any of your questions - and have the answers," he said.Dr Land said he had been fearing a botulism outbreak for years, noticing more and more businesses in the region offering injections that were suspiciously cheap.
An investigation into the cause of the recent cases of botulism is being led by the UK Health Security Agency with partners including Durham County Council's public health team. Director of public health Amanda Healy said they were urging anyone with symptoms to seek treatment. An incident management team had been set up to deal with the issue and they were working out if the cause of these incidents of botulism was the "type of toxin used or the way it was used", she said.
Mrs Fairley says the business owner who gave her the injections has apologised. "I know she hasn't done this on purpose," Mrs Fairley says. "I just don't know where people get it from - it's scary. "There needs to be more rules and stricter guidelines on who can do it - not just anybody who can go and do a course and just do it. "There's that many people who do it - it's part of your beauty regime like getting your nails done or your hair." What happened, and the continuing side effects, has put Mrs Fairley off having cosmetic injections again. She urges anyone considering it to ask questions about the product and make sure it has been properly prescribed. The Department of Health and Social Care (DHSC) said people's lives were being put at risk by "inadequately trained operators in the cosmetic sector" and said this was why the government was looking into new regulations."We urge anyone considering cosmetic procedures to consider the possible health impacts and find a reputable, insured and qualified practitioner," a spokesperson said.
Follow BBC North East on X, Facebook, Nextdoor and Instagram.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lucy Letby colleague wins legal case over hospital visits probe
Lucy Letby colleague wins legal case over hospital visits probe

BBC News

time2 minutes ago

  • BBC News

Lucy Letby colleague wins legal case over hospital visits probe

A former colleague of Lucy Letby has won a High Court claim against the NHS trust where he works over an investigation into what he knew about the killer nurse when he arranged for her to visit another as Dr MN because he testified at Letby's first criminal trial, he said the trust, which also cannot be identified, breached his contract because of how it proposed to investigate consultant had formerly worked at the Countess of Chester Hospital on the same neonatal unit as Letby - who is serving 15 whole life terms for murdering seven babies and attempting to murder six Justice Sheldon ruled in the doctor's favour at the High Court earlier. The court was told that after moving to another hospital, Dr MN had arranged for several supervised visits for Letby to the new hospital in late 2016 and early had told his trust's deputy chief medical officer about his involvement in the trial and how he was involved in supervised visits for Letby at the trust's chief medical officer prepared a draft letter saying he was content Dr MN "had no knowledge of the circumstances surrounding Letby at the time of the visits", Mr Justice Sheldon wrote in his judgment.A few days later, however, the trust received a complaint from a mother of a baby who had been treated by Dr MN which alleged he shared confidential information about her son with Letby by email and Facebook. 'Term of contract' The trust then told Dr MN it wanted to investigate him over what he knew about Letby when she visited their MN said the trust breached its employment contract because it wanted to appoint someone other than its chief medical officer to oversee the judge ruled: "It is a term of Dr MN's contract of employment that the case manager should be the medical director, in this case, the chief medical officer, for the matters that are the subject of the present investigation."Letby, 35, who has always maintained her innocence, lost two bids last year to challenge her convictions at the Court of Criminal Cases Review Commission, which investigates potential miscarriages of justice, is reviewing her convictions. Earlier this month, prosecutors revealed they were considering bringing further charges against her following the deaths and non-fatal collapses of babies at hospitals where she worked. Listen to the best of BBC Radio Merseyside on Sounds and follow BBC Merseyside on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.

Why men don't talk to the GP about prostate cancer
Why men don't talk to the GP about prostate cancer

Telegraph

time2 minutes ago

  • Telegraph

Why men don't talk to the GP about prostate cancer

Men are often more familiar with Formula 1 world champions than they are with signs of prostate cancer, research has found. A new survey has exposed widespread confusion among men about prostate cancer and prostate health more widely. The poll found that 27 per cent of men could name more leading racing drivers than signs of prostate problems. Meanwhile, a third were too shy to speak to their GP about their problems, while almost half were unaware of how screening worked. A quarter believed they did not need to be checked unless they had symptoms. Why we're campaigning for change The Telegraph is campaigning for the introduction of targeted screening so those most at risk, such as black men and those with a family history of disease, are offered PSA tests. Experts are also calling for current NHS guidance to be rewritten so that GPs are told to discuss prostate cancer risks with men, rather than waiting to see if they bring it up. Prostate cancer often has no symptoms in its early stages. When symptoms do appear, they can include changes in urination, such as needing to urinate more frequently, especially at night, difficulty starting or stopping urination, a weak urine stream, and a feeling that the bladder has not emptied completely. However, urination problems are also common in old age, as well as being linked to other less serious problems. Persistent back pain, fatigue and weight loss can be symptoms of advanced disease. Early diagnosis is critical Late diagnosis is linked to far worse survival. Men diagnosed with prostate cancer at an early stage have five-year survival rates of almost 100 per cent. This compares to rates of around 50 per cent once it has spread beyond the prostate. Every year, around 55,000 men are diagnosed with prostate cancer, making it the most common cancer in men, with 12,000 deaths. However, prostate cancer is the only major cancer with no screening programme. The poll of 2,000 men by Vista Health found 35 per cent have delayed or avoided speaking to a healthcare professional about potential prostate issues. Embarrassment was the most common reason, cited by 16 per cent. Widespread ignorance Twenty-six per cent of respondents did not know where the prostate is located and 65 per cent could not confidently explain its function (it makes semen and controls the flow of urine). A fifth of men wrongly believed the prostate was located in the bladder, when the small gland is actually below. More than a quarter of men said they had sought tests after public figures spoke out. It comes after The Telegraph revealed that almost 5,000 extra men have been referred by the NHS for urological cancer in the six months after Sir Chris Hoy, 49, the six-time Olympic cycling gold medallist, spoke about his diagnosis. The polling found that a quarter of men said they were also more likely to undergo checks if encouraged by their partners, while four in ten said the y would do so for peace of mind. The polling was commissioned by Vista Health, which offers a prostate screening service, including PSA blood testing and MRI where needed. Dr Reem Hasan, the chief medical officer at Vista Health, said: 'These findings are a real wake-up call. Many men are understandably worried about prostate cancer, but too often they don't fully understand what the prostate is, what it does, or whether they may be at increased risk. That confusion can quickly become fear and sadly, fear can delay action. Empowerment over embarrassment 'We urgently need to replace myths with facts, and embarrassment with empowerment. Prostate health should not be a taboo topic. Getting checked does not have to be invasiv e or uncomfortable. A simple PSA blood test, followed by an MRI if needed, can offer clarity and real peace of mind.' The UK National Screening Committee (UK NSC) is currently considering whether to recommend the rollout of testing. In the past, it has rejected the idea because of concern that PSA tests are too unreliable, and would result in too many men undergoing needless procedures. However, in recent years the back-up technology used to confirm a diagnosis has significantly improved, with hopes that further advances being tested in Prostate Cancer UK's Transform trial could mean that, in future, screening could cut deaths by 40 per cent.

Farmers and scientists join forces in Cornwall to vaccinate badgers against TB
Farmers and scientists join forces in Cornwall to vaccinate badgers against TB

The Guardian

time33 minutes ago

  • The Guardian

Farmers and scientists join forces in Cornwall to vaccinate badgers against TB

The first farmer-led programme to vaccinate badgers against tuberculosis is beginning in Cornwall with an aim to prevent transmission of the disease to cattle. The programme is significant because farmers and scientists have long been at loggerheads over the culling of badgers as a way to control TB. The three-year trial will start with 70 farms and involve farmers trapping, testing and vaccinating badgers, with training provided by scientists. An earlier pilot study of the approach showed TB rates in badgers fell from 16% to zero in four years. TB can devastate cattle herds and more than 20,000 infected cattle were slaughtered in the last year in England. The badger cull started in 2013 and has killed about 250,000 badgers but has been highly controversial. Most scientists have argued since the start that culling can make no meaningful contribution to TB control in cattle, based on a large-scale trial from 1998 to 2005. They say most cattle are infected by other cattle and that controlling livestock movements are key. Most farmers argue that badgers are a dangerous reservoir for the disease and must be controlled. The results of the culling to date are contested. Badger culling is due to end in 2029. The £1.4m project is the first time the National Farmers' Union has led a badger vaccination programme. Previous badger vaccination trials have been conducted by wildlife groups. Prof Rosie Woodroffe, at the Institute of Zoology in London, said: 'For half a century, wildlife advocates and farmers have argued about the best way to manage the risk of TB transmission between badgers and cattle. Ultimately, we all want the same thing: to see TB eliminated so that farmers, their livestock, and wildlife can all thrive. 'By working together to compare different approaches, we can develop a shared understanding of the evidence and use it to identify TB control solutions which are effective and sustainable.' Bridget Whell, a farmer and the NFU's Cornwall chair, is taking part in the project and has 1,200 cattle serving two dairies. She has lost half the cattle from one of the dairies in the past and her farm has spent most of the last 15 years under government restrictions due to TB infections. 'It was really devastating,' she said. There have been six years of badger culling on Whell's farm but that have now ended due to the government's decision to end culling. 'It does seem now that in terms of the tools available, aside from biosecurity and [cattle] testing, [badger vaccination] is the future,' she said. Cattle vaccines for TB are being developed but have been complicated by the need to be able to distinguish between infected and vaccinated animals when they are tested. 'There's been a lack of confidence [about badger vaccination] because there's been no information,' Whell said. 'What we hope to ultimately get out of [the project] is whether [badger vaccination] affects the cattle levels of TB – that remains to be seen, but I think it's well worth doing.' 'My scepticism, if any, is whether this is as a policy is sustainable, financially and practically.' The project will begin with 70 farmers over 80km2 in Cornwall, and expand over three years to cover 400 to 500km2. It will assess the impact of badger vaccination on TB control and examine how vaccination can be scaled up and delivered in the most cost-efficient way. The project will assess three vaccination approaches to determine which works best: annual vaccination over four years, vaccination every other year or reactive vaccination based on TB infection on farms.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store